Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowton, D.
Right arrow Articles by Stump, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowton, D.
Right arrow Articles by Stump, D.

Chest, Vol 94, 371-375, Copyright © 1988 by American College of Chest Physicians

ARTICLES

Theophylline effect on the cerebral blood flow response to hypoxemia

DL Bowton, WS Haddon, DS Prough, N Adair, PT Alford and DA Stump
Department of Anesthesia (Critical Care), Wake Forest University Medical Center, Winston-Salem, NC.

Cerebral oxygen delivery (CO2D) remains nearly constant over a wide range of cerebral perfusion pressure and arterial oxygen content. In response to a decrease in arterial oxygen content secondary to hypoxemia, cerebral blood flow (CBF) increases, a response likely mediated by the release of adenosine. We studied the effect of theophylline, a potent adenosine antagonist, on CBF and cerebral oxygen delivery (CO2D) during hypoxemia in five healthy adult male volunteers. The CBF was measured using 133Xe clearance under conditions of (1) normoxemia (O2 saturation greater than 95 percent); (2) hypoxemia (O2 saturation = 80 percent); (3) normoxemia following aminophylline (the ethylene diamine salt of theophylline) 6 mg/kg intravenously; and (4) hypoxemia following aminophylline. Aminophylline decreased CBF and CO2D during both normoxemia and hypoxemia, but did not prevent the increase in CBF accompanying hypoxemia, suggesting that the increase in CBF in response to hypoxemia may not be mediated by adenosine or that customary doses of aminophylline are insufficient to inhibit adenosine- mediated cerebral vasodilation in response to hypoxemia. The significant decrease in CBF and CO2D observed following aminophylline is potentially clinically important and should be considered in the selection of bronchodilator therapy.


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
I. Mitrouska, E. Kondili, G. Prinianakis, N. Siafakas, and D. Georgopoulos
Effects of Theophylline on Ventilatory Poststimulus Potentiation in Patients with Brain Damage
Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1124 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
M. Miyabe, K. Tajima, H. Takahashi, and H. Toyooka
Olprinone, a phosphodiesterase III inhibitor, does not affect hypoxia-induced pial arteriolar dilatation in rabbits: [L'olprinone, un inhibiteur de la phosphodiesterase III, n'a pas d'effet sur la dilatation arteriolaire pie-merienne chez les lapins]
Can J Anesth, February 1, 2003; 50(2): 193 - 197.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. Weinberger and L. Hendeles
Theophylline in Asthma
N. Engl. J. Med., May 23, 1996; 334(21): 1380 - 1388.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American College of Chest Physicians.